Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses 5.99 M6.52 M7.76 M — Research & development 13.67 M15.38 M16.04 M — Operating income 19.66 M21.91 M23.8 M — Non-Operating Income, Total 3.18 M3.84 M3.53 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 3 M3.67 M3.46 M — Unusual income/expense 177 K171 K71 K — Pretax income 22.84 M25.74 M27.33 M — Equity in earnings ——— — Taxes ——— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 16.48 M18.07 M20.28 M — Discontinued operations ——— — Net income 16.48 M18.07 M20.28 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 16.48 M18.07 M20.28 M — Basic earnings per share (Basic EPS) 620410-0.46 — Diluted earnings per share (Diluted EPS) 620410-0.46 — Average basic shares outstanding 26.6 M44.12 M44.26 M — Diluted shares outstanding 26.6 M44.12 M44.26 M — EBITDA ——— — EBIT ——— — Cost of revenue ——— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) -497 K-1.07 M-736 K —